Rollnik J D, Bertram M, Bucka C, Hartwich M, Jöbges M, Ketter G, Leineweber B, Mertl-Rötzer M, Nowak D A, Platz T, Scheidtmann K, Thomas R, von Rosen F, Wallesch C W, Woldag H, Peschel P, Mehrholz J, Pohl M
Institute for Neurorehabilitation Research (InFo), BDH-Klinik Hessisch Oldendorf, Hannover Medical School (MHH), Greitstr. 18-28, 31840, Hess. Oldendorf, Germany.
Kliniken Schmieder Heidelberg, Heidelberg, Germany.
BMC Neurol. 2017 Mar 20;17(1):53. doi: 10.1186/s12883-017-0833-2.
Colonization or infection with multi-drug resistant (MDR) bacteria is considered detrimental to the outcome of neurological and neurosurgical early rehabilitation patients.
In a German multi-center study, 754 neurological early rehabilitation patients were enrolled and and reviewed in respect to MDR status, length of stay (LOS) and the following outcome variables: Barthel Index (BI), Early Rehabilitation Index (ERI), Glasgow Outcome Score Extended (GOSE), Coma Remission Scale (CRS), Functional Ambulation Categories (FAC).
The mean age of the study population was 68.0 ± 14.8 years. Upon admission, the following prevalence for MDRs was observed: MRSA (methicillin resistant staphylococcus aureus) 7.0% (53/754), ESBL- (extended spectrum beta-lactamase) producing bacteria strains 12.6% (95/754), VRE (vancomycin resistant enterococci) 2.8% (21/754). Patients colonized or infected with MDR bacteria (MDR+) were significantly more frequently diagnosed with a critical illness polyneuropathy - CIP - than non-colonized (MDR-) patients: 29.0% vs. 14.8%. In addition, they were more frequently mechanically ventilated (MDR+: 55/138, 39.9%; MDR- 137/616, 22.2%). MDR+ patients were referred to rehabilitation earlier, had a longer LOS in early rehabilitation, lower BI on admission and at discharge, lower ERI on admission and lower CRS at discharge than MDR- patients. There was a highly significant correlation of the BI upon admission with the BI at discharge (r = 0.492, p < 0.001). GOSE at discharge differed significantly between both groups (χ -test, p < 0.01). Perhaps of greatest importance, mortality among MDR+ was higher in comparison to MDR- (18.1% vs. 7.6%).
The outcome of neurological early rehabilitation patients colonized or infected with MDR bacteria including MRSA or ESBL producing strains is significantly poorer than by non-colonized patients. There is some evidence that the poor outcome could be related to the higher morbidity and lower functional status upon admission.
多重耐药(MDR)菌的定植或感染被认为对神经科和神经外科早期康复患者的预后不利。
在一项德国多中心研究中,纳入了754例神经科早期康复患者,并对其MDR状态、住院时间(LOS)以及以下结局变量进行了评估:Barthel指数(BI)、早期康复指数(ERI)、格拉斯哥扩展结局量表(GOSE)、昏迷缓解量表(CRS)、功能步行分类(FAC)。
研究人群的平均年龄为68.0±14.8岁。入院时,观察到以下MDR的患病率:耐甲氧西林金黄色葡萄球菌(MRSA)7.0%(53/754),产超广谱β-内酰胺酶(ESBL)菌株12.6%(95/754),耐万古霉素肠球菌(VRE)2.8%(21/754)。与未定植(MDR-)患者相比,定植或感染MDR菌(MDR+)的患者被诊断为重症多发性神经病(CIP)的频率显著更高:29.0%对14.8%。此外,他们接受机械通气的频率也更高(MDR+:55/138,39.9%;MDR-:137/616,22.2%)。与MDR-患者相比,MDR+患者更早被转诊至康复机构,早期康复住院时间更长,入院时和出院时的BI更低,入院时的ERI更低,出院时的CRS更低。入院时的BI与出院时的BI高度相关(r = 0.492,p < 0.001)。两组出院时的GOSE有显著差异(χ检验,p < 0.01)。也许最重要的是,MDR+患者的死亡率高于MDR-患者(18.1%对7.6%)。
定植或感染包括MRSA或产ESBL菌株在内的MDR菌的神经科早期康复患者的预后明显比未定植患者差。有证据表明,预后不良可能与入院时较高的发病率和较低的功能状态有关。